Source: International Congress 2016 – Monitoring airway diseases with clinical tools
Disease area: Airway diseases

Abstract

INTRODUCTION:According to the EPI-SCAN study there is significant under-diagnosis in COPD, at around 73%. Therefore, it is essential to develop strategies to reduce this underdiagnosis.OBJECTIVE:It was to determine the percentage of COPD underdiagnosis in the area of influence of the hospital of Ourense.METHODS:Epidemiological, cross-sectional multicenter study in the health area of Ourense where a team composed by a nurse and pulmonologist attended to 16 health centers, in the period from December 12th 2012 to July 2nd 2013. Spirometric tests were performed to previously selected patients, according to the following characteristics: age> 35 years, smokers or former smokers with a pack-year index > 10, non-smokers with chronic symptoms (dyspnea, cough and expectoration of more than 6 months). We excluded patients with previous diagnosis of respiratory diseases or under any type of inhaled treatment. Main variable: % of patients diagnosed with COPD.RESULTS:A number of 405 patients from a total of 409 were selected and analyzed. From these, 35.6% (n 144) were diagnosed with COPD and 64.4% (n 261) showed no symptoms of the disease. The average age of the patients was 61.07 years (standard deviation +12, 39). 79.8% of them were males (n 115), with a history of smoking in 81% of them, and exposed to smoke in 59.7%.On the other hand, 19% (n 27) of them had no history of smoking, 41% (n 12) being women. Of the positive COPD patients, 31% show mild, and 52% moderate symptoms.CONCLUSIONS:The under-diagnosis of COPD in patients at risk is 35.6%. Most of them are diagnosed at mild or moderate stages of the disease. About 20% of diagnosed patients diagnosed are non-smokers.


Rating:

Share or cite this content

Citations should be made in the following way:
Nagore Blanco Cid (Ourense, Spain), Nagore Blanco Cid, Pedro J. Marcos, Isaura Parente Lamelas, Hugo Gomez Marquez, Jose Abal Arca, Pedro Marcos Velazquez. IE-3 study. Impact of a specialized intervention in the diagnosis of COPD. Eur Respir J 2016; 48: Suppl. 60, 1050

Member's Comments

No comment yet.

Related content which might interest you: Spirometry interpretation for primary care: A validation study Source: Annual Congress 2013 –Early diagnosis and effectiveness of disease management in primary care Year: 2013 Efficacy of early COPD diagnosis and intervention system Source: International Congress 2014 – Physical activity, exercise and physiotherapy in patients with COPD Year: 2014 Diagnostic characteristics of questionnaires for identification of obstructive lung disease Source: International Congress 2016 – Prevalence, prognosis, and risk factors of COPD Year: 2016 Tackling under-diagnosis of COPD using spirometry and questionnaire: A targeted, case-finding study Source: International Congress 2015 – Epidemiology, public health and economics of tobacco Year: 2015 Justification for statistical process control in daily home spirometry for COPD patients Source: Annual Congress 2013 –Disease control and quality of life in airway diseases Year: 2013 Comparison of modified medical research council scale and COPD assessment test in subjects with COPD Source: International Congress 2016 – Screening, diagnosis, assessment, and treatment of COPD in primary care Year: 2016 Spirometry is not enough to make clinical diagnosis of COPD Source: International Congress 2016 – Screening, diagnosis, assessment, and treatment of COPD in primary care Year: 2016 Assessment of the COPD patients’ care: An audit of clinical practice Source: Annual Congress 2013 –Quality of life and respiratory symptoms in primary care COPD populations Year: 2013 The impact of comorbidities on pulmonary rehabilitation outcomes in patients with COPD Source: International Congress 2016 – Hospitalisation and comorbidities in chronic lung diseases Year: 2016 Modelling the long-term effects of an active case finding programme for undiagnosed COPD Source: International Congress 2016 – Prevalence, prognosis, and risk factors of COPD Year: 2016 The relevance of lung function tests in an intensive smoking cessation program Source: Annual Congress 2013 –E-cigarettes, shisha, the tobacco industry and public health Year: 2013 Case-finding for COPD: Developing strategies to identify patients at risk populations Source: International Congress 2015 – Epidemiology of respiratory disease Year: 2015 Romanian experience in running COPD awareness campaigns Source: International Congress 2016 – Public health related concerns and epidemiology of smoking and smoking-related products Year: 2016 Accuracy of questionnaire with peak flow for diagnosis of airway obstruction and differentiating between asthma and COPD Source: International Congress 2015 – Respiratory disease management in primary care Year: 2015 Effect of primary-care spirometry on the diagnosis and management of COPD Source: Eur Respir J 2006; 28: 945-952 Year: 2006 Smart phone-based platform for diagnosing asthma and COPD Source: International Congress 2016 – Non-inflammatory assessment of airway disorders Year: 2016 COPD assessment for symptoms and functional condition in pulmonary rehabilitation Source: International Congress 2015 – Functional capacity, exercise and pulmonary rehabilitation in chronic lung diseases Year: 2015 Respiratory point of care testing (R-POCT) to facilitate diagnosis and treatment in the community for COPD exacerbations Source: International Congress 2019 – COPD treatment: clinical trials, cohorts and inhaler device studies Year: 2019 Is early diagnosis of COPD possible? Preliminary results of early COPD study Source: International Congress 2014 – Monitoring airway diseases with lung function tests Year: 2014 Predictors of COPD in high risk individuals seen in primary care Source: International Congress 2016 – Comorbidities and exacerbations in COPD Year: 2016